Farther Finance Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
RG
CDDEC
AAMU
AIM
AV
MIF
ZIC
Farther Finance Advisors's AZN Position: Q2 2026 in Review
Farther Finance Advisors opened a new position in AstraZeneca (AZN) in Q2 2026: 11,882 shares worth $2.25M. The stake represents 0.02% of the portfolio and ranks #682 among its holdings. This is a return to the name: Farther Finance Advisors previously reported a position in AZN as recently as Q4 2025.
Farther Finance Advisors first reported a position in AZN in Q4 2022 and has held it in 14 quarters since. 406 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Farther Finance Advisors held 11,882 shares of AstraZeneca worth $2.25M as of Q2 2026.
- AstraZeneca was a new Farther Finance Advisors position in Q2 2026.
- AstraZeneca made up 0.02% of Farther Finance Advisors's portfolio in Q2 2026, its #682 holding.
- Farther Finance Advisors first reported a position in AstraZeneca in Q4 2022 and has held it in 14 quarters since.
- 406 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.